Ernexa highlights ovarian cancer treatment challenges in investor segment
Go back to Ernexa highlights ovarian cancer treatment challenges in investor segment| (NASDAQ: ERNA) | Delayed: 4.05 -0.4 (8.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.45 | 52 Week High | $ | |||
| Open | $4.33 | 52 Week Low | $ | |||
| Day High | $4.46 | P/E | N/A | |||
| Day Low | $4.00 | EPS | $ | |||
| Volume | 52,730 | |||||

